메뉴 건너뛰기




Volumn 75, Issue 7-8, 2012, Pages 337-345

Analytical and preparative chiral separation of β-carboline derivatives, LDL oxidation inhibitors, using HPLC and CE methodologies: Determination of enantiomeric purity

Author keywords

Carbolines; Chiral CE; Chiral HPLC; Highly sulfated cyclodextrins; Polysaccharide CSP

Indexed keywords

BETA CARBOLINE DERIVATIVE; CYCLODEXTRIN; HEXANE; LOW DENSITY LIPOPROTEIN;

EID: 84862877210     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1007/s10337-012-2194-8     Document Type: Article
Times cited : (12)

References (27)
  • 11
    • 84862876354 scopus 로고
    • FDA's policy statement for the development of new ste-reoisomeric drugs
    • (1992) FDA's policy statement for the development of new ste-reoisomeric drugs
    • (1992)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.